| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Section of Immunology and Cell Biology, NIH, National Cancer Institute, Baltimore Cancer Research Center, Baltimore, Maryland 21211
Antispleen antibody was produced in burros by immunization with C57BL/6 spleen lymphocytes. The effect of passive administration of this antiserum in inhibiting antibody production to antigenic determinants common to both C57BL/6 lymphocytes and EL4 tumor cells was studied. Simultaneous immunization with EL4 cells and antispleen antibody resulted in specific alteration of anti-EL4 activity so that cross-reactivity to splenic lymphocytes was diminished. These results demonstrate the potential usefulness of passive antibody administration in altering host immunological responsiveness to antigenic determinants on tumor cells.
Received 2/16/72. Accepted 4/ 3/72.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |